Cvsl Inc. (CVSL) 2.20 $CVSL
Upside Potential In RBC Life Sciences
Duane Bair - at Seeking Alpha - Tue Apr 21, 2:24PM CDT
BTH: 7.75 (+0.04), CVSL: 2.20 (+0.16)
CVSL Continues Climbing List Of Top Global Direct Sellers
PR Newswire - Mon Apr 20, 10:44PM CDT
CVSL Inc. [NYSE MKT: CVSL] has been recognized on two recent direct selling industry rankings. Direct Selling News has named CVSL as #84 on the 2015 Global 100 list of the top revenue-generating direct selling companies in the world. It also has ranked CVSL as #45 on the 2015 North America 50, which lists the top direct selling companies in North America.
CVSL: 2.20 (+0.16)
Top 100 Global 'Best in Stock Markets' Medical Devices/Technology/Supplies Compamnies 2015
M2 - Wed Apr 15, 8:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wxtwtv/global_best_in) has announced the addition of the "Global Best in Stock Markets Medical Devices/Technology/Supplies 100" report to their offering. This newly launched report identifies 100 Best in Stock Markets medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. Medical devices sector constitutes a fast growing global market with innovative devices providing breakthroughs in earlier and better diagnoses and medical treatments that bring clinical benefits to patients at a cost savings to the healthcare system and the individual patients. The medical device industry might not be the perfect industry for a long-term investor - there are some issues on the horizon and new frictional costs that keep it from being sublime. But no industry is perfect, and if there was one, the market would just overbuy it and it'd become too expensive anyway. Medical devices are pretty close to perfect, despite the ongoing intellectual property wars between competitors, and a new medical device tax courtesy of the Affordable Healthcare Act. 2014 has turned out to be a pretty decent year for the world's 40 largest medical device companies. Only six of them have seen their stock prices decline, and the gainers on an average have seen stock prices increase about 27%. Some are doing even better, either because of unexpected sales growth or because they are acquisition targets. Report Highlights: - Global Best in Stock Markets 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and Stock market performances - Important M&A and alliances of Global Best in Stock Markets medical devices/technology/supplies companies with foreign companies - International presence of Global Best in Stock Markets medical devices/technology/supplies companies - Key R&D activities by Global Best in Stock Markets medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 3: Key News of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies with foreign companies 5: Research and Development Activities by Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 6: International Presence of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies Sample list of company names included in this industry report: - A&T Corporation (Japan) - Abaxis Inc. (United States) - Abiomed, Inc. (United States) - Advanced Oncotherapy PLC (United Kingdom) - Affymetrix, Inc. (United States) - Andon Health Company Limited (China) - Asahi Intecc Co., Ltd. (Japan) - Atcor Medical Holdings Ltd (Australia) - Atect Corp (Japan) - Beijing Bohui Innovation Tech (China) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosino Bio-Technology & Science Incorporation (Hong Kong) - Blue Sail Medical Co Ltd (China) - Boule Diagnostics AB (Sweden) - Capitol Health Ltd (Australia) - Careplus Group Berhad (Malaysia) - Cellavision AB (Sweden) - Changsha Kaiyuan Instruments Co Ltd (China) - Compumedics Limited (Australia) - Cormedix (United States) - CVSL Inc (United States) - DongGuan Eontec Co, Ltd (China) - El.En SpA (Italy) - Guangdong Shirongzhaoye Co. Ltd. (China) - Lifeloc Technologies Inc. (United States) - Mani Incorporated (Japan) - Milestone Scientific Inc. (United States) - Netcare Limited (South Africa) - Tristel PLC (United Kingdom) - WaferGen Bio-systems, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/wx...al_best_in
CVSL: 2.20 (+0.16), WGBS: 4.66 (-0.08), AFFX: 12.57 (-0.13), ABAX: 63.25 (-0.09)
CVSL: Roll-Up Strategy Offers Huge Value Creation Potential, Triple-Digit Returns Possible
AlphaSeeksMe - at Seeking Alpha - Mon Mar 30, 5:19PM CDT
CVSL: 2.20 (+0.16)
CVSL Funds And Closes Acquisition Of Kleeneze
PR Newswire - Wed Mar 25, 2:00AM CDT
CVSL Inc. [NYSE MKT: CVSL] announced today that it has successfully funded and closed its previously-announced acquisition of Kleeneze, one of the UK's longest-operating, largest and best-known direct-to-consumer businesses. With the addition of Kleeneze, CVSL's business portfolio expands to nine companies.
CVSL: 2.20 (+0.16)
CVSL Inc. Releases Year-End 2014 Results
PR Newswire - Mon Mar 16, 5:00PM CDT
CVSL Inc. [NYSE MKT: CVSL] today released results for the year ended December 31, 2014, its second year of operation as a federation of direct-to-consumer companies.
CVSL: 2.20 (+0.16)
CVSL To Hold Investor Information Call On March 16
PR Newswire - Wed Mar 11, 6:05PM CDT
CVSL Inc. [NYSE MKT: CVSL] announced today that it will hold an investor information call on Monday, March 16 at 6 p.m. Eastern Time.
CVSL: 2.20 (+0.16)
Market Maker Surveillance Report. OCN, WTW, RESN, ENOC, CVSL, TUBE, Losing Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Oceanus Resources Corp (NYSE:OCN), Weight Watchers International Inc (NYSE:WTW), REGENCY RES INC (NASDAQ:RESN), ENERNOC, INC. (NASDAQ:ENOC), Computer Vision Systems Laboratories Corp (NYSE:CVSL), (NASDAQ:TUBE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
RESN: 3.77 (-0.06), OCN: 7.68 (+0.14), TUBE: 15.54 (+0.04), ENOC: 11.19 (+0.02), CVSL: 2.20 (+0.16), WTW: 7.81 (+0.16)
CVSL Stock Closed Lower Today After Pricing Public Offering
at The Street - Fri Feb 27, 3:38PM CST
Shares of CVSL closed down after the company announced the pricing of an underwritten public offering of 6,667,000 shares of common stock and warrants at a combined price of $3.
CVSL: 2.20 (+0.16)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:15AM CST
MNST: 139.91 (+0.06), SREV: 3.35 (+0.02), OCN: 7.68 (+0.14), ARUN: 24.59 (+0.01), CVSL: 2.20 (+0.16), NBG: 1.19 (+0.12), CLNE: 7.16 (+0.03), RESN: 3.77 (-0.06), ATOS: 1.65 (+0.03), CYCC: 0.94 (-0.03), NVAX: 8.51 (+0.09), CYTX: 0.96 (-0.09), TUBE: 15.54 (+0.04), HZNP: 30.96 (+0.10), PBPB: 14.60 (+0.18), SD: 1.86 (-0.06), FRO: 2.77 (-0.20), TBIO: 1.74 (-0.02), BLOX: 24.25 (+0.11), DRL: 0.72 (-0.62), GENE: 4.88 (-0.05), MOSY: 2.20 (-0.09), XIN: 3.34 (+0.09), JCP: 8.56 (-0.02), MEET: 1.73 (-0.05), VIMC: 13.42 (+1.31), SPLK: 65.92 (+1.69), WTW: 7.81 (+0.16)
CVSL Signs Agreement To Acquire Kleeneze
PR Newswire - Fri Feb 06, 3:30AM CST
CVSL Inc. [NYSE MKT: CVSL] announced today that it has signed an agreement to acquire Kleeneze, a United Kingdom-based direct-to-consumer company. The consummation of the acquisition is subject to certain conditions, including approval by the New York Stock Exchange MKT.
CVSL: 2.20 (+0.16)
CVSL To Hold Investor Information Call On January 21
PR Newswire - Fri Jan 16, 1:43PM CST
CVSL Inc. [NYSE MKT: CVSL] announced today that it will hold an investor information call on Wednesday, January 21 at 4:30 p.m. Eastern Time
CVSL: 2.20 (+0.16)
CVSL Files S-3 Shelf Registration Statement
PR Newswire - Wed Dec 03, 5:01PM CST
CVSL Inc. [NYSE MKT: CVSL] said today that is has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) to allow the Company to raise up to $100 million in incremental capital on an as-needed basis for acquisitions and general working capital.
CVSL: 2.20 (+0.16)
CVSL Inc. Will Begin Trading On New York Stock Exchange This Friday
PR Newswire - Wed Dec 03, 2:28PM CST
The common stock of CVSL Inc. [NYSE MKT: CVSL] will begin trading on the New York Stock Exchange MKT this coming Friday, December 5. Confirmation of the uplisting was received today from the NYSE.
CVSL: 2.20 (+0.16)
Rochon Capital Partners Reaffirms Plan On Second Tranche Shares
PR Newswire - Sun Nov 30, 8:35PM CST
John Rochon Jr., Vice Chairman of CVSL Inc. [OTCQX: CVSL] reaffirmed today that Rochon Capital Partners will continue with its plan to restrict its right to receive its Second Tranche Shares in CVSL, thereby eliminating any overhang as a result of those shares to shareholders and potential investors.
CVSL: 2.20 (+0.16)
CVSL Expects to Uplist Within Next Several Trading Days, Says Its Strategy for 2015 Will Focus on Acquisitions
PR Newswire - Fri Nov 28, 7:30PM CST
CVSL Inc. [OTCQX: CVSL] said today that, with its uplisting to a national securities exchange expected within several trading days, the Company intends to immediately re-focus on its acquisition strategy within the direct-to-consumer channel.
CVSL: 2.20 (+0.16)
OTC Markets Group Congratulates CVSL on NYSE MKT Listing
PR Newswire - Wed Nov 05, 8:21AM CST
OTC Markets Group Inc. (OTCQX: OTCM) congratulates CVSL Inc. on its approval to list on the NYSE MKT, effective November 5, 2014. CVSL previously traded on OTCQX®, the best marketplace for established global and growth companies operated by OTC Markets Group.
CVSL: 2.20 (+0.16)
In Preparation For Planned NYSE MKT Uplisting, CVSL Announces Reverse Stock Split
PR Newswire - Fri Oct 17, 5:00AM CDT
CVSL Inc. (OTC QX: CVSL) announced that, in preparation for its planned uplisting to the NYSE MKT and to conform with NYSE MKT listing requirements, it is effecting a 1-for-20 reverse stock split of its common stock, to be effective for trading purposes as of the commencement of trading today, October 17, 2014. As of this date, each 20 shares of issued and outstanding common stock will be converted into one share of common stock.
CVSL: 2.20 (+0.16)
CVSL Receives Notification On Authorization For NYSE MKT Listing
PR Newswire - Tue Aug 26, 3:00PM CDT
CVSL Inc. (OTC QX: CVSL) has received notification that it has been authorized for listing on the NYSE MKT, contingent upon CVSL being in compliance with all listing standards on the date it begins trading on the Exchange.
CVSL: 2.20 (+0.16)
CVSL Inc. Releases Quarterly Results
PR Newswire - Thu Aug 14, 3:43PM CDT
CVSL Inc. (OTC QX: CVSL) today released its results for the quarter ended June 30, 2014.
CVSL: 2.20 (+0.16)
Upside Potential In RBC Life Sciences
Duane Bair - at Seeking Alpha - Tue Apr 21, 2:24PM CDT
BTH: 7.75 (+0.04), CVSL: 2.20 (+0.16)
CVSL Continues Climbing List Of Top Global Direct Sellers
PR Newswire - Mon Apr 20, 10:44PM CDT
CVSL Inc. [NYSE MKT: CVSL] has been recognized on two recent direct selling industry rankings. Direct Selling News has named CVSL as #84 on the 2015 Global 100 list of the top revenue-generating direct selling companies in the world. It also has ranked CVSL as #45 on the 2015 North America 50, which lists the top direct selling companies in North America.
CVSL: 2.20 (+0.16)
Top 100 Global 'Best in Stock Markets' Medical Devices/Technology/Supplies Compamnies 2015
M2 - Wed Apr 15, 8:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wxtwtv/global_best_in) has announced the addition of the "Global Best in Stock Markets Medical Devices/Technology/Supplies 100" report to their offering. This newly launched report identifies 100 Best in Stock Markets medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. Medical devices sector constitutes a fast growing global market with innovative devices providing breakthroughs in earlier and better diagnoses and medical treatments that bring clinical benefits to patients at a cost savings to the healthcare system and the individual patients. The medical device industry might not be the perfect industry for a long-term investor - there are some issues on the horizon and new frictional costs that keep it from being sublime. But no industry is perfect, and if there was one, the market would just overbuy it and it'd become too expensive anyway. Medical devices are pretty close to perfect, despite the ongoing intellectual property wars between competitors, and a new medical device tax courtesy of the Affordable Healthcare Act. 2014 has turned out to be a pretty decent year for the world's 40 largest medical device companies. Only six of them have seen their stock prices decline, and the gainers on an average have seen stock prices increase about 27%. Some are doing even better, either because of unexpected sales growth or because they are acquisition targets. Report Highlights: - Global Best in Stock Markets 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and Stock market performances - Important M&A and alliances of Global Best in Stock Markets medical devices/technology/supplies companies with foreign companies - International presence of Global Best in Stock Markets medical devices/technology/supplies companies - Key R&D activities by Global Best in Stock Markets medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 3: Key News of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies with foreign companies 5: Research and Development Activities by Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 6: International Presence of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies Sample list of company names included in this industry report: - A&T Corporation (Japan) - Abaxis Inc. (United States) - Abiomed, Inc. (United States) - Advanced Oncotherapy PLC (United Kingdom) - Affymetrix, Inc. (United States) - Andon Health Company Limited (China) - Asahi Intecc Co., Ltd. (Japan) - Atcor Medical Holdings Ltd (Australia) - Atect Corp (Japan) - Beijing Bohui Innovation Tech (China) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosino Bio-Technology & Science Incorporation (Hong Kong) - Blue Sail Medical Co Ltd (China) - Boule Diagnostics AB (Sweden) - Capitol Health Ltd (Australia) - Careplus Group Berhad (Malaysia) - Cellavision AB (Sweden) - Changsha Kaiyuan Instruments Co Ltd (China) - Compumedics Limited (Australia) - Cormedix (United States) - CVSL Inc (United States) - DongGuan Eontec Co, Ltd (China) - El.En SpA (Italy) - Guangdong Shirongzhaoye Co. Ltd. (China) - Lifeloc Technologies Inc. (United States) - Mani Incorporated (Japan) - Milestone Scientific Inc. (United States) - Netcare Limited (South Africa) - Tristel PLC (United Kingdom) - WaferGen Bio-systems, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/wx...al_best_in
CVSL: 2.20 (+0.16), WGBS: 4.66 (-0.08), AFFX: 12.57 (-0.13), ABAX: 63.25 (-0.09)
CVSL: Roll-Up Strategy Offers Huge Value Creation Potential, Triple-Digit Returns Possible
AlphaSeeksMe - at Seeking Alpha - Mon Mar 30, 5:19PM CDT
CVSL: 2.20 (+0.16)
CVSL Funds And Closes Acquisition Of Kleeneze
PR Newswire - Wed Mar 25, 2:00AM CDT
CVSL Inc. [NYSE MKT: CVSL] announced today that it has successfully funded and closed its previously-announced acquisition of Kleeneze, one of the UK's longest-operating, largest and best-known direct-to-consumer businesses. With the addition of Kleeneze, CVSL's business portfolio expands to nine companies.
CVSL: 2.20 (+0.16)
CVSL Inc. Releases Year-End 2014 Results
PR Newswire - Mon Mar 16, 5:00PM CDT
CVSL Inc. [NYSE MKT: CVSL] today released results for the year ended December 31, 2014, its second year of operation as a federation of direct-to-consumer companies.
CVSL: 2.20 (+0.16)
CVSL To Hold Investor Information Call On March 16
PR Newswire - Wed Mar 11, 6:05PM CDT
CVSL Inc. [NYSE MKT: CVSL] announced today that it will hold an investor information call on Monday, March 16 at 6 p.m. Eastern Time.
CVSL: 2.20 (+0.16)
Market Maker Surveillance Report. OCN, WTW, RESN, ENOC, CVSL, TUBE, Losing Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Oceanus Resources Corp (NYSE:OCN), Weight Watchers International Inc (NYSE:WTW), REGENCY RES INC (NASDAQ:RESN), ENERNOC, INC. (NASDAQ:ENOC), Computer Vision Systems Laboratories Corp (NYSE:CVSL), (NASDAQ:TUBE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
RESN: 3.77 (-0.06), OCN: 7.68 (+0.14), TUBE: 15.54 (+0.04), ENOC: 11.19 (+0.02), CVSL: 2.20 (+0.16), WTW: 7.81 (+0.16)
CVSL Stock Closed Lower Today After Pricing Public Offering
at The Street - Fri Feb 27, 3:38PM CST
Shares of CVSL closed down after the company announced the pricing of an underwritten public offering of 6,667,000 shares of common stock and warrants at a combined price of $3.
CVSL: 2.20 (+0.16)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:15AM CST
MNST: 139.91 (+0.06), SREV: 3.35 (+0.02), OCN: 7.68 (+0.14), ARUN: 24.59 (+0.01), CVSL: 2.20 (+0.16), NBG: 1.19 (+0.12), CLNE: 7.16 (+0.03), RESN: 3.77 (-0.06), ATOS: 1.65 (+0.03), CYCC: 0.94 (-0.03), NVAX: 8.51 (+0.09), CYTX: 0.96 (-0.09), TUBE: 15.54 (+0.04), HZNP: 30.96 (+0.10), PBPB: 14.60 (+0.18), SD: 1.86 (-0.06), FRO: 2.77 (-0.20), TBIO: 1.74 (-0.02), BLOX: 24.25 (+0.11), DRL: 0.72 (-0.62), GENE: 4.88 (-0.05), MOSY: 2.20 (-0.09), XIN: 3.34 (+0.09), JCP: 8.56 (-0.02), MEET: 1.73 (-0.05), VIMC: 13.42 (+1.31), SPLK: 65.92 (+1.69), WTW: 7.81 (+0.16)
CVSL Signs Agreement To Acquire Kleeneze
PR Newswire - Fri Feb 06, 3:30AM CST
CVSL Inc. [NYSE MKT: CVSL] announced today that it has signed an agreement to acquire Kleeneze, a United Kingdom-based direct-to-consumer company. The consummation of the acquisition is subject to certain conditions, including approval by the New York Stock Exchange MKT.
CVSL: 2.20 (+0.16)
CVSL To Hold Investor Information Call On January 21
PR Newswire - Fri Jan 16, 1:43PM CST
CVSL Inc. [NYSE MKT: CVSL] announced today that it will hold an investor information call on Wednesday, January 21 at 4:30 p.m. Eastern Time
CVSL: 2.20 (+0.16)
CVSL Files S-3 Shelf Registration Statement
PR Newswire - Wed Dec 03, 5:01PM CST
CVSL Inc. [NYSE MKT: CVSL] said today that is has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) to allow the Company to raise up to $100 million in incremental capital on an as-needed basis for acquisitions and general working capital.
CVSL: 2.20 (+0.16)
CVSL Inc. Will Begin Trading On New York Stock Exchange This Friday
PR Newswire - Wed Dec 03, 2:28PM CST
The common stock of CVSL Inc. [NYSE MKT: CVSL] will begin trading on the New York Stock Exchange MKT this coming Friday, December 5. Confirmation of the uplisting was received today from the NYSE.
CVSL: 2.20 (+0.16)
Rochon Capital Partners Reaffirms Plan On Second Tranche Shares
PR Newswire - Sun Nov 30, 8:35PM CST
John Rochon Jr., Vice Chairman of CVSL Inc. [OTCQX: CVSL] reaffirmed today that Rochon Capital Partners will continue with its plan to restrict its right to receive its Second Tranche Shares in CVSL, thereby eliminating any overhang as a result of those shares to shareholders and potential investors.
CVSL: 2.20 (+0.16)
CVSL Expects to Uplist Within Next Several Trading Days, Says Its Strategy for 2015 Will Focus on Acquisitions
PR Newswire - Fri Nov 28, 7:30PM CST
CVSL Inc. [OTCQX: CVSL] said today that, with its uplisting to a national securities exchange expected within several trading days, the Company intends to immediately re-focus on its acquisition strategy within the direct-to-consumer channel.
CVSL: 2.20 (+0.16)
OTC Markets Group Congratulates CVSL on NYSE MKT Listing
PR Newswire - Wed Nov 05, 8:21AM CST
OTC Markets Group Inc. (OTCQX: OTCM) congratulates CVSL Inc. on its approval to list on the NYSE MKT, effective November 5, 2014. CVSL previously traded on OTCQX®, the best marketplace for established global and growth companies operated by OTC Markets Group.
CVSL: 2.20 (+0.16)
In Preparation For Planned NYSE MKT Uplisting, CVSL Announces Reverse Stock Split
PR Newswire - Fri Oct 17, 5:00AM CDT
CVSL Inc. (OTC QX: CVSL) announced that, in preparation for its planned uplisting to the NYSE MKT and to conform with NYSE MKT listing requirements, it is effecting a 1-for-20 reverse stock split of its common stock, to be effective for trading purposes as of the commencement of trading today, October 17, 2014. As of this date, each 20 shares of issued and outstanding common stock will be converted into one share of common stock.
CVSL: 2.20 (+0.16)
CVSL Receives Notification On Authorization For NYSE MKT Listing
PR Newswire - Tue Aug 26, 3:00PM CDT
CVSL Inc. (OTC QX: CVSL) has received notification that it has been authorized for listing on the NYSE MKT, contingent upon CVSL being in compliance with all listing standards on the date it begins trading on the Exchange.
CVSL: 2.20 (+0.16)
CVSL Inc. Releases Quarterly Results
PR Newswire - Thu Aug 14, 3:43PM CDT
CVSL Inc. (OTC QX: CVSL) today released its results for the quarter ended June 30, 2014.
CVSL: 2.20 (+0.16)
